Prices for drugs in Russia may rise significantly as soon as the beginning of 2019, according to recent statements by an official spokesman of the Russian Pharmacy Guild, a public association, which unites Russian leading pharmacies and some local drugmakers, reports The Pharma Letter’s local correspondent.
Analysts expect the growth of prices will be in the range of 15%-20%, while the main reason of this will be weak rouble and generally low purchasing power of local customers.
It is predicted that the biggest growth will be observed in the case of imported drugs. At the same time prices will also grow for locally-made drugs, as some of their components, particularly active ingredients, are still imported into Russia.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze